相似文献
1
The pharmaceutical price regulation scheme.
BMJ. 2007 Mar 3;334(7591):435-6. doi: 10.1136/bmj.39136.464421.BE.
2
Regulating the pharmaceutical industry. Authors seem to have misunderstood pharmaceutical price regulation scheme.
BMJ. 1998 Jan 17;316(7126):226; author reply 228.
3
Time to fix the price fix.
Health Serv J. 1997 Nov 6;107(5578):22-3.
4
Regulating the pharmaceutical industry. Regulation may no longer be necessary.
BMJ. 1998 Jan 17;316(7126):227; author reply 228.
5
NHS spending on drugs is frozen for two years under price deal.
BMJ. 2013 Nov 7;347:f6731. doi: 10.1136/bmj.f6731.
6
Regulating the pharmaceutical industry.
BMJ. 1997 Jul 26;315(7102):200-1. doi: 10.1136/bmj.315.7102.200.
7
Pharma focus. Market traders.
Health Serv J. 2003 Nov 27;113(5883):suppl 2-3.
8
Changes to the regulation of drug prices in the UK.
BMJ. 2008 Dec 29;337:a2735. doi: 10.1136/bmj.a2735.
9
Waiving the rules.
Health Serv J. 1992 Jun 4;102(5305):20-2.
10
New drug pricing scheme could politicise decisions and reduce access, says think tank.
BMJ. 2013 May 8;346:f2965. doi: 10.1136/bmj.f2965.
引用本文的文献
1
Systematic review of the impact of the National Medication Price Negotiated Policy on the accessibility of drugs in China, 2016-2024.
BMJ Open. 2024 Dec 26;14(12):e087190. doi: 10.1136/bmjopen-2024-087190.
2
Impact of medical insurance access negotiation on the utilization of innovative anticancer drugs in China: an interrupted time series analysis.
BMC Health Serv Res. 2024 Jan 17;24(1):90. doi: 10.1186/s12913-023-10393-y.
3
Experts' views on how to design a tobacco control fund in the UK.
BMJ Open. 2022 Nov 28;12(11):e066224. doi: 10.1136/bmjopen-2022-066224.
4
Oncology drugs for orphan indications: how are HTA processes evolving for this specific drug category?
Clinicoecon Outcomes Res. 2017 Jun 10;9:327-342. doi: 10.2147/CEOR.S134230. eCollection 2017.
5
Value based pricing for NHS drugs: an opportunity not to be missed?
BMJ. 2008 Feb 2;336(7638):251-4. doi: 10.1136/bmj.39434.500185.25.
6
Having your cake and eating it: office of fair trading proposal for funding new drugs to benefit patients and innovative companies.
Pharmacoeconomics. 2008;26(2):91-8. doi: 10.2165/00019053-200826020-00001.
7
Parliamentary review asks NICE to do better still.
BMJ. 2008 Jan 12;336(7635):56-7. doi: 10.1136/bmj.39454.496748.80.
Zotero 插件